{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:20Z","timestamp":1753890980841,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The association of pro-inflammatory markers such as interleukin-6 (IL-6) and other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest, however their kinetics, response to current COVID-related treatments, association with disease severity and comparison with other disease states associated with potential cytokine storm (CS) such as Staphylococcus aureus bacteraemia (SAB) are ill-defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cohort of 55 hospitalized SARS-CoV-2 positive patients was prospectively recruited \u2013 blood sampling was performed at baseline, post-treatment and hospital discharge. Serum IL-6, C-reactive protein (CRP) and other laboratory investigations were compared between treatment groups and across timepoints. Acute serum IL-6 and CRP levels were then compared to those with suspected COVID-19 (SCOVID) and age and sex matched patients with SAB and patients hospitalized for any non-infectious condition (NIC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IL-6 was elevated at admission in the SARS-CoV-2 cohort but at lower levels compared to matched SAB patients. Median (IQR) IL-6 at admission was 73.89 pg\/mL (30.9, 126.39) in SARS-CoV-2 compared to 92.76 pg\/mL (21.75, 246.55) in SAB (p=0.017); 12.50 pg\/mL (3.06, 35.77) in patients with NIC; and 95.51 pg\/mL (52.17, 756.67) in SCOVID. Median IL-6 and CRP levels decreased between admission and discharge timepoints. This reduction was amplified in patients treated with remdesivir and\/or dexamethasone. CRP and bedside vital signs were the strongest predictors of COVID-19 severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Knowledge of the kinetics of IL-6 did not offer enhanced predictive value for disease severity in COVID-19 over common investigations such as CRP and vital signs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.646095","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T04:42:29Z","timestamp":1615956149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy\u2014A Prospective Longitudinal Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Ana","family":"Copaescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie","family":"Mouhtouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia C.","family":"Smibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Drewett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.16.20023903","article-title":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jaci.2020.07.009","article-title":"IL-6-based mortality risk model for hospitalized patients with COVID-19","volume":"146","author":"Laguna-Goya","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"unstructured":"National Institutes of Health (NIH)Management of Persons with COVID-192020","key":"B5"},{"key":"B6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12879-018-3011-2","article-title":"Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia","volume":"18","author":"Holmes","year":"2018","journal-title":"BMC Infect Dis"},{"key":"B7","article-title":"[P096] ANTI-STAPHYLOCOCCAL ANTIBODY PROFILE IN AUSTRALIAN PATIENTS WITH Staphylococcus aureus BACTERAEMIA","volume-title":"International Symposium on Staphylococci and Staphylococcal Infections","author":"Holmes","year":"2018"},{"unstructured":"Product datasheet - Human IL-6 ELISA Kit2017","key":"B8"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243414","article-title":"COVID-MATCH65 \u2013 A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2. medRxiv","author":"Trubiano","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0022","article-title":"The biology and medical implications of interleukin-6","volume":"2","author":"Tanaka","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000505099","article-title":"Interleukin-6: A Masterplayer in the Cytokine Network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd6197","article-title":"Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19","volume":"5","author":"Mann","year":"2020","journal-title":"Sci Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s13054-020-03255-0","article-title":"Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China","volume":"24","author":"Zeng","year":"2020","journal-title":"Crit Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.jaip.2020.06.013","article-title":"Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study","volume":"8","author":"Vultaggio","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.01.20047381","article-title":"Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. medRxiv","author":"Herold","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17052","article-title":"Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions","author":"Kox","year":"2020","journal-title":"JAMA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.646095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T04:42:35Z","timestamp":1615956155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.646095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2021.646095"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.646095","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"article-number":"646095"}}